(January 21, 2020, 1:38 PM EST) -- SAN FRANCISCO — The Ninth Circuit U.S. Court of Appeals on Jan. 16 said plaintiffs claiming to suffer withdrawal symptoms from the antidepressant Cymbalta cannot reopen their case after they voluntarily dismissed the case in a now-banned tactic to get appellate review of adverse lower court rulings (Melissa Strafford, et al. v. Eli Lilly and Company, No. 18-56064, 9th Cir., 2020 U.S. App. LEXIS 1717)....